Market Overview

Benzinga's Top Pre-Market Losers

Share:
Related PAY
VeriFone Posts Upbeat Q3 Results, But Issues Weak Forecast
Verifone Sees Q4 EPS $0.47-$0.48 vs Est $0.51 & Revs $510M-$513M Vs Est $521.93M; FY EPS Revs $1.997B-$2.0B Vs Est $2.00B
VeriFone lower after FQ3 beat, soft FQ4 guidance (Seeking Alpha)
Related ISIS
Isis Pharma 8-K Filing Shows Company Enters Agreement with Astrazeneca To Discover And Develop Antisense Drugs FOr Cardiovascular, Metabolic And Renal Disease
AstraZeneca, Isis Pharmaceuticals to Collaborate to Develop Antisense Drugs for Cardiovascular, Metabolic and Renal Diseases

VeriFone Systems (NYSE: PAY) shares fell 6.65% to $31.02 in the pre-market trading. VeriFone reported an 86% drop in its fiscal fourth-quarter profit and issued downbeat first-quarter forecast.

Isis Pharmaceuticals (NASDAQ: ISIS) shares dropped 9.47% to $8.70 in pre-market trading. Isis Pharmaceuticals and Genzyme reported that the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a negative opinion for its marketing authorization application for KYNAMRO.

Clearwire (NASDAQ: CLWR) dipped 3.16% to $3.06 in the pre-market session. Sprint Nextel (NYSE: S) is offering $2.90 per share to acquire the rest of Clearwire.

Apple (NASDAQ: AAPL) dipped 1.92% to $519.50 in the pre-market session. Apple's trailing-twelve-month ROA is 23.61%.

Posted-In: Top Pre-Market LosersNews Movers & Shakers Pre-Market Outlook Markets

 

Related Articles (AAPL + CLWR)

Get Benzinga's Newsletters